Cibinqo
Abrocitinib · U.S. Pharmaceuticals
CANCER MEDICINE · PRESCRIPTION ONLY (USA)Cibinqo ingredients
| Active ingredient | Strength |
|---|---|
| Abrocitinib | 200 mg/1, 100 mg/1, 50 mg/1 |
What Cibinqo is used for
Cibinqo is a cancer medicine (janus kinase inhibitor). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Cibinqo
- Generic name
- Abrocitinib
- Made by
- U.S. Pharmaceuticals
- Forms
- Tablet, Film Coated
- Given
- Oral
- Drug class
- Janus Kinase Inhibitor
- FDA approval
- New drug application (NDA) NDA213871
- On the US market since
- 2022
Official information
- MedlinePlus drug information (search for Abrocitinib)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Cibinqo?
Cibinqo (Abrocitinib) is a cancer medicine made by U.S. Pharmaceuticals, approved by the US FDA.
What are the ingredients of Cibinqo?
Cibinqo contains Abrocitinib (200 mg/1, 100 mg/1, 50 mg/1).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA